EUVIMEDEUVIMED entdecken
Crossref

Involvement of impaired phosphate production and aberrant extracellular ATP signaling in the pathogenesis of hypophosphatasia: Analysis of ALPL-Knockout human iPS cell models

Miwa Yamazaki, Ayu Ueta, Tatsuro Nakanishi, Kanako Tachikawa, Masanobu Kawai, Keiichi Ozono, Toshimi Michigami

Bone · 2025

DOI: 10.1016/j.bone.2025.117629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone, 2025. Verfasst von Miwa Yamazaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Izumi, O…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Hypophosphatasia, Alkaline Phosphatase, Phosphates. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Alexion Pharmaceuticals, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypophosphatasia (HPP) is caused by inactivating variants of ALPL, the gene encoding tissue non-specific alkaline phosphatase (TNSALP). In order to deepen our understanding of the pathogenic mechanisms of HPP, we herein generated ALPL-knockout (KO) human induced pluripotent stem (iPS) cells by applying CRISPR/Cas9-mediated gene deletion to an iPS clone derived from a healthy subject. We analyzed two ALPL-KO clones, one ALPL-hetero KO clone, and a control clone isogenic except for ALPL. In an osteogenic culture using β-glycerophosphate, which generates inorganic phosphate (Pi) by TNSALP-mediated degradation, ALPL-KO clones showed impaired mineralization, elevated levels of extracellular pyrophosphate (PPi), and reduced levels of extracellular Pi. Osteogenic induction using 3 mM Pi instead of β-glycerophosphate rescued the decreased content of hydroxyapatite in ALPL-KO cells despite the still high levels of extracellular PPi; however, abnormal distribution of hydroxyapatite was noted. Osteoblast lineage cells differentiated from ALPL-KO iPS clones showed the up-regulation of SPP1 and the down-regulation of ANKH and the genes for type III sodium/phosphate co-transporters in the culture using β-glycerophosphate, but not when 3 mM Pi was used. Extracellular ATP levels were elevated in osteoblast lineage cells derived from ALPL-KO iPS clones in both culture conditions, which was associated with the down-regulation of P2X7 encoding a purinergic receptor. Moreover, osteoblast lineage cells differentiated from ALPL-KO iPS clones in the culture using β-glycerophosphate showed a change in cellular response to extracellular Pi. These results suggest that the reduced local production of extracellular Pi and aberrant ATP signaling play substantial roles in the pathogenesis of HPP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsHypophosphatasiaAlkaline PhosphatasePhosphatesAdenosine TriphosphateSignal TransductionModels, BiologicalExtracellular SpaceHumansGene Knockout TechniquesOsteogenesisCell DifferentiationOsteoblastsCRISPR-Cas Systems

Stichwörter der Autor:innen

ALPLCRISPR/Cas9Induced pluripotent stem cellsmineralizationosteoblasttissue non-specific alkaline phosphatase

Substanzen

Alkaline PhosphatasePhosphatesALPL protein, humanAdenosine Triphosphate

Autor:innen und Institutionen

  • Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Izumi, Osaka, 594-1101, Japan.
  • Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Izumi, Osaka, 594-1101, Japan; 1st Department of Oral and Maxillofacial Surger…
  • Department of Molecular Genetics and Endocrinology, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Izumi, Osaka, 594-1101, Japan.
  • Center for Promoting Treatment of Intractable Diseases, Iseikai International General Hospital, Osaka, Osaka, 530-0052, Japan.
  • Department of Bone and Mineral Research, Research Institute, Osaka Women's and Children's Hospital, Osaka Prefectural Hospital Organization, Izumi, Osaka, 594-1101, Japan. Electronic address: michigami@wch.opho.jp.

Förderung

  • Alexion Pharmaceuticals
  • Japan Society for the Promotion of Science

Zitieren

APA

Yamazaki, M., Ueta, A., Nakanishi, T., Tachikawa, K., Kawai, M., Ozono, K., & Michigami, T. (2025). Involvement of impaired phosphate production and aberrant extracellular ATP signaling in the pathogenesis of hypophosphatasia: Analysis of ALPL-Knockout human iPS cell models. Bone. https://doi.org/10.1016/j.bone.2025.117629

Vancouver

Yamazaki M, Ueta A, Nakanishi T, Tachikawa K, Kawai M, Ozono K, et al. Involvement of impaired phosphate production and aberrant extracellular ATP signaling in the pathogenesis of hypophosphatasia: Analysis of ALPL-Knockout human iPS cell models. Bone. 2025. doi:10.1016/j.bone.2025.117629

BibTeX
@article{Yamazaki2025,
  author = {Yamazaki, Miwa and Ueta, Ayu and Nakanishi, Tatsuro and Tachikawa, Kanako and Kawai, Masanobu and Ozono, Keiichi and Michigami, Toshimi},
  title = {Involvement of impaired phosphate production and aberrant extracellular ATP signaling in the pathogenesis of hypophosphatasia: Analysis of ALPL-Knockout human iPS cell models},
  journal = {Bone},
  year = {2025},
  doi = {10.1016/j.bone.2025.117629}
}
Kostenlos starten →